Overview of Dr. Larson
Dr. Melissa Larson is a hematologist in Chicago, IL and is affiliated with multiple hospitals in the area, including Rush University Medical Center and Rush Oak Park Hospital. She received her medical degree from Rush Medical College of Rush University Medical Center and has been in practice 17 years. Dr. Larson accepts several types of health insurance, listed below. She is one of 22 doctors at Rush University Medical Center and one of 8 doctors at Rush Oak Park Hospital who specialize in Hematology. She has more than 10 publications and over 200 citings.
Office
1725 W Harrison St
Ste 809
Chicago, IL 60612
Education & Training
- Rush University Medical CenterResidency, Internal Medicine, 2000 - 2003
- Rush Medical College of Rush University Medical CenterClass of 2000
Certifications & Licensure
- IL State Medical License 2000 - 2026
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Phase III Study of CPX-351 Versus 7+3 in Patients 60-75 Years Old With Untreated High Risk (Secondary) Acute Myeloid Leukemia Start of enrollment: 2012 Dec 13
- Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML Start of enrollment: 2018 Aug 15
Roles: Contact
Publications & Presentations
PubMed
- 47 citationsStructural racism is a mediator of disparities in acute myeloid leukemia outcomes.Ivy Elizabeth Abraham, Garth H Rauscher, Anand Ashwin Patel, William B Pearse, Priya Rajakumar
Blood. 2022-04-07 - 2 citationsClofarabine: a new treatment option for patients with acute myeloid leukemia.Melissa L. Larson, Parameswaran Venugopal
Expert Opinion on Pharmacotherapy. 2009-05-23 - 23 citationsSecondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)Se young Han, Krzysztof Mrózek, Jenna M. Voutsinas, Qian Wu, Elizabeth A. Morgan
Blood Advances. 2021-05-25
Abstracts/Posters
- Role of Racial, Demographic and Socioeconomic Disparities in Treatment Patterns and Outcomes in AMLMelissa L. Larson, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Lectures
- Final Safety and Efficacy Results from the CPX-351 Early Access Program (EAP) for Older Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML)2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Timed sequential therapy with high-dose cytarabine and mitoxantrone as an effective and safe induction regimen for acute myeloid leukemia.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
- Study Shows Structural Racism Can Result in Poorer Leukemia OutcomesMarch 7th, 2022
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois BlueChoice Select
BCBS Illinois PPO
BCBS Oklahoma BlueChoice
CIGNA HMO
CIGNA Open AccessCIGNA PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: